Acute Coronary Syndromes
Mark your calendars now to experience the premier global event focusing on improving health by championing scientific discovery and practice-changing educational content. We can't wait to see you November 2023!We Welcome Your Ideas
What would you like to see at Scientific Sessions 2023? This is your chance to help us create next year's conference.
Submit your vision before December 15 at 6 p.m. Central Time.
The 3CPR Council’s areas of focus encompass integrated cardiopulmonary physiology, critical care, emergency cardiovascular care, and CPR. The council takes a bench-to-bedside and community approach to clinical care, research, and basic science. Pulmonary hypertension and regulation of pulmonary circulation have been topics of ongoing attention.
The CVSN Council accelerates the discovery, interpretation, and application of science to enhance cardiovascular health and treat cardiovascular diseases and stroke. The council helps develop scientific statements and advisories, guide professional education activities, provide scientific expertise, conduct research, translate findings, and promote evidence-based practices in clinical settings.
The CLCD Council supports AHA objectives in clinical cardiology, promotes excellent clinical care, and fosters professional development and education for clinical cardiologists. Through council-sponsored symposia, panels, and scientific conferences, members can access and interpret new developments in the field and promote clinical cardiology to professional and lay audiences.
The CVSA Council includes surgeons, anesthesiologists and scientists interested in cardiac, vascular, and thoracic interventions. Involved in basic science and clinical trials, the council seeks to increase awareness of important issues in cardiovascular surgery and anesthesia, disseminate new knowledge, and encourage use of optimal surgical procedures and anesthetic techniques.
The CVRI Council’s mission is to provide leadership to the AHA to reduce death and disability from cardiovascular, peripheral vascular, and cerebrovascular diseases, using diagnostic and functional imaging and imaging-directed interventions. Council members work to provide outstanding research, education, outreach, and mentorship opportunities.
Principal investigator A. Michael Lincoff, MD summarizes the results of the STRENGTH Trial, which looked at the effects of omega-3 carboxylic acid on clinical outcomes in patients at high cardiovascular risk.